Concepts (249)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Streptococcal Infections | 9 | 2020 | 244 | 3.480 |
Why?
|
| Prenatal Care | 7 | 2024 | 340 | 3.250 |
Why?
|
| Pregnancy Complications, Infectious | 12 | 2023 | 441 | 2.970 |
Why?
|
| Streptococcus agalactiae | 8 | 2020 | 105 | 2.600 |
Why?
|
| Gynecology | 4 | 2022 | 126 | 2.430 |
Why?
|
| Obstetrics | 5 | 2022 | 233 | 2.360 |
Why?
|
| Antibiotic Prophylaxis | 5 | 2020 | 116 | 1.960 |
Why?
|
| Pregnancy | 43 | 2024 | 7101 | 1.720 |
Why?
|
| Chorioamnionitis | 2 | 2021 | 41 | 1.530 |
Why?
|
| Fetal Membranes, Premature Rupture | 2 | 2021 | 60 | 1.470 |
Why?
|
| Version, Fetal | 2 | 2020 | 7 | 1.460 |
Why?
|
| Social Media | 2 | 2022 | 107 | 1.260 |
Why?
|
| Cesarean Section | 7 | 2023 | 380 | 0.990 |
Why?
|
| Periodicals as Topic | 2 | 2019 | 187 | 0.940 |
Why?
|
| Pregnancy Trimester, Third | 4 | 2020 | 109 | 0.900 |
Why?
|
| Delphi Technique | 2 | 2024 | 200 | 0.870 |
Why?
|
| Labor Stage, Second | 1 | 2023 | 20 | 0.860 |
Why?
|
| Female | 51 | 2024 | 64939 | 0.830 |
Why?
|
| Vaginal Birth after Cesarean | 2 | 2020 | 23 | 0.830 |
Why?
|
| Neonatal Sepsis | 1 | 2022 | 29 | 0.800 |
Why?
|
| Pelvic Organ Prolapse | 1 | 2022 | 27 | 0.800 |
Why?
|
| Endometritis | 1 | 2021 | 9 | 0.790 |
Why?
|
| Surgical Mesh | 1 | 2022 | 62 | 0.790 |
Why?
|
| Breech Presentation | 2 | 2020 | 21 | 0.770 |
Why?
|
| Penicillins | 2 | 2020 | 154 | 0.770 |
Why?
|
| Venous Thromboembolism | 2 | 2020 | 162 | 0.720 |
Why?
|
| Humans | 62 | 2024 | 122412 | 0.720 |
Why?
|
| Extracorporeal Membrane Oxygenation | 3 | 2023 | 624 | 0.700 |
Why?
|
| Peripartum Period | 1 | 2020 | 31 | 0.700 |
Why?
|
| Prenatal Diagnosis | 2 | 2018 | 581 | 0.670 |
Why?
|
| Sexism | 1 | 2019 | 36 | 0.670 |
Why?
|
| Vulvar Lichen Sclerosus | 1 | 2019 | 6 | 0.670 |
Why?
|
| Genitalia, Female | 1 | 2019 | 48 | 0.640 |
Why?
|
| Platelet Count | 1 | 2019 | 130 | 0.640 |
Why?
|
| Drug Hypersensitivity | 1 | 2020 | 96 | 0.630 |
Why?
|
| Cervix Uteri | 2 | 2017 | 70 | 0.630 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2019 | 70 | 0.630 |
Why?
|
| Patient Preference | 1 | 2019 | 102 | 0.630 |
Why?
|
| Liability, Legal | 1 | 2018 | 44 | 0.630 |
Why?
|
| Lacerations | 1 | 2019 | 34 | 0.620 |
Why?
|
| Fetal Death | 1 | 2018 | 115 | 0.610 |
Why?
|
| Anti-Bacterial Agents | 4 | 2020 | 2391 | 0.610 |
Why?
|
| Stillbirth | 1 | 2018 | 80 | 0.610 |
Why?
|
| Delivery, Obstetric | 3 | 2022 | 253 | 0.560 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 2020 | 237 | 0.560 |
Why?
|
| Parturition | 1 | 2017 | 62 | 0.550 |
Why?
|
| Betacoronavirus | 1 | 2020 | 289 | 0.540 |
Why?
|
| Bias | 1 | 2017 | 113 | 0.540 |
Why?
|
| Data Interpretation, Statistical | 1 | 2017 | 201 | 0.530 |
Why?
|
| Pandemics | 2 | 2022 | 1103 | 0.520 |
Why?
|
| Obstetric Labor Complications | 3 | 2007 | 96 | 0.520 |
Why?
|
| Infant, Newborn | 13 | 2023 | 8113 | 0.520 |
Why?
|
| Carrier State | 1 | 2015 | 76 | 0.500 |
Why?
|
| Telemedicine | 2 | 2021 | 420 | 0.500 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2017 | 1025 | 0.490 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 361 | 0.480 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 378 | 0.470 |
Why?
|
| Physicians | 1 | 2019 | 582 | 0.420 |
Why?
|
| Pregnancy Outcome | 6 | 2024 | 592 | 0.410 |
Why?
|
| United States | 7 | 2024 | 10475 | 0.400 |
Why?
|
| Internship and Residency | 1 | 2022 | 1152 | 0.390 |
Why?
|
| Biomedical Research | 1 | 2017 | 510 | 0.370 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 2813 | 0.370 |
Why?
|
| Cerclage, Cervical | 2 | 2007 | 11 | 0.350 |
Why?
|
| Pregnancy Complications | 4 | 2021 | 503 | 0.350 |
Why?
|
| Sepsis | 1 | 2014 | 478 | 0.350 |
Why?
|
| Erythromycin | 2 | 2021 | 18 | 0.330 |
Why?
|
| Adult | 18 | 2024 | 28743 | 0.320 |
Why?
|
| Retrospective Studies | 14 | 2023 | 15879 | 0.320 |
Why?
|
| Anticoagulants | 2 | 2020 | 583 | 0.310 |
Why?
|
| Genetic Testing | 1 | 2014 | 994 | 0.300 |
Why?
|
| Cost-Benefit Analysis | 2 | 2020 | 490 | 0.290 |
Why?
|
| Gestational Age | 3 | 2023 | 1118 | 0.290 |
Why?
|
| Hospitals, Community | 2 | 2007 | 54 | 0.290 |
Why?
|
| Uterus | 2 | 2007 | 593 | 0.290 |
Why?
|
| Constriction, Pathologic | 2 | 2007 | 237 | 0.290 |
Why?
|
| Hospitals, University | 1 | 2007 | 95 | 0.280 |
Why?
|
| Candidiasis, Vulvovaginal | 1 | 2006 | 9 | 0.270 |
Why?
|
| Prothrombin Time | 1 | 2006 | 36 | 0.260 |
Why?
|
| Fluconazole | 1 | 2006 | 47 | 0.260 |
Why?
|
| Cerebral Palsy | 1 | 2007 | 79 | 0.250 |
Why?
|
| Pregnancy Complications, Cardiovascular | 2 | 1997 | 103 | 0.250 |
Why?
|
| Warfarin | 1 | 2006 | 119 | 0.240 |
Why?
|
| Appointments and Schedules | 1 | 2024 | 49 | 0.230 |
Why?
|
| Vagina | 3 | 2021 | 202 | 0.220 |
Why?
|
| Fetal Viability | 1 | 2023 | 29 | 0.220 |
Why?
|
| Decision Making | 2 | 2020 | 650 | 0.220 |
Why?
|
| Antifungal Agents | 1 | 2006 | 293 | 0.220 |
Why?
|
| Labor Stage, First | 1 | 2023 | 7 | 0.210 |
Why?
|
| Parity | 1 | 2023 | 79 | 0.210 |
Why?
|
| Practice Guidelines as Topic | 2 | 2020 | 1247 | 0.210 |
Why?
|
| China | 1 | 2023 | 234 | 0.210 |
Why?
|
| Surgical Instruments | 1 | 2021 | 57 | 0.190 |
Why?
|
| Azithromycin | 1 | 2021 | 45 | 0.190 |
Why?
|
| Postpartum Hemorrhage | 1 | 2022 | 90 | 0.190 |
Why?
|
| Pain, Postoperative | 2 | 2021 | 253 | 0.190 |
Why?
|
| Pregnancy, Multiple | 3 | 2014 | 50 | 0.190 |
Why?
|
| Urinary Retention | 1 | 2021 | 17 | 0.180 |
Why?
|
| Morbidity | 1 | 2021 | 239 | 0.180 |
Why?
|
| Hysterectomy | 1 | 2022 | 182 | 0.180 |
Why?
|
| Consensus | 1 | 2024 | 607 | 0.180 |
Why?
|
| Respiratory Insufficiency | 1 | 2023 | 234 | 0.180 |
Why?
|
| Desogestrel | 1 | 2020 | 6 | 0.180 |
Why?
|
| Point-of-Care Systems | 1 | 2023 | 172 | 0.180 |
Why?
|
| Simulation Training | 1 | 2022 | 139 | 0.180 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2021 | 70 | 0.170 |
Why?
|
| Contraceptive Agents, Female | 1 | 2020 | 29 | 0.170 |
Why?
|
| Contraception | 1 | 2020 | 60 | 0.170 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2019 | 27 | 0.170 |
Why?
|
| Uterine Contraction | 2 | 1997 | 28 | 0.170 |
Why?
|
| Birth Injuries | 1 | 1999 | 21 | 0.170 |
Why?
|
| Abortion, Spontaneous | 1 | 2020 | 85 | 0.160 |
Why?
|
| Choice Behavior | 1 | 2019 | 131 | 0.160 |
Why?
|
| Middle Aged | 5 | 2021 | 25588 | 0.160 |
Why?
|
| Overweight | 1 | 2021 | 313 | 0.160 |
Why?
|
| Heart Rate, Fetal | 1 | 2018 | 64 | 0.150 |
Why?
|
| Twins | 2 | 2014 | 68 | 0.150 |
Why?
|
| Maternal Age | 1 | 2018 | 135 | 0.150 |
Why?
|
| Endometriosis | 1 | 2021 | 185 | 0.150 |
Why?
|
| Probability | 1 | 2018 | 318 | 0.150 |
Why?
|
| Nausea | 1 | 2018 | 97 | 0.150 |
Why?
|
| Reference Values | 1 | 2019 | 695 | 0.150 |
Why?
|
| Rectus Abdominis | 1 | 1997 | 10 | 0.140 |
Why?
|
| Anesthesia | 1 | 2020 | 209 | 0.140 |
Why?
|
| Postoperative Complications | 2 | 2022 | 2998 | 0.140 |
Why?
|
| Abruptio Placentae | 1 | 1997 | 17 | 0.140 |
Why?
|
| Vomiting | 1 | 2018 | 116 | 0.140 |
Why?
|
| Robotic Surgical Procedures | 1 | 2021 | 198 | 0.140 |
Why?
|
| Heart Diseases | 2 | 2019 | 479 | 0.140 |
Why?
|
| Dystocia | 1 | 1997 | 23 | 0.140 |
Why?
|
| Patient Readmission | 1 | 2020 | 364 | 0.140 |
Why?
|
| Betamethasone | 1 | 1996 | 13 | 0.140 |
Why?
|
| Treatment Outcome | 3 | 2022 | 12035 | 0.140 |
Why?
|
| Muscular Diseases | 1 | 1997 | 103 | 0.140 |
Why?
|
| Hematoma | 1 | 1997 | 93 | 0.130 |
Why?
|
| Terbutaline | 1 | 1996 | 6 | 0.130 |
Why?
|
| Tocolytic Agents | 1 | 1996 | 12 | 0.130 |
Why?
|
| Prospective Studies | 4 | 2021 | 5970 | 0.130 |
Why?
|
| Evidence-Based Medicine | 1 | 2020 | 607 | 0.130 |
Why?
|
| Chlamydia trachomatis | 1 | 1995 | 21 | 0.130 |
Why?
|
| Societies, Medical | 1 | 2020 | 673 | 0.130 |
Why?
|
| Patient Satisfaction | 1 | 2019 | 473 | 0.130 |
Why?
|
| Gastroplasty | 1 | 1995 | 10 | 0.130 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 602 | 0.130 |
Why?
|
| Odds Ratio | 2 | 2015 | 1231 | 0.130 |
Why?
|
| Diseases in Twins | 1 | 1996 | 94 | 0.130 |
Why?
|
| Coronary Aneurysm | 1 | 1996 | 33 | 0.130 |
Why?
|
| Chlamydia Infections | 1 | 1995 | 45 | 0.130 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 1996 | 79 | 0.130 |
Why?
|
| Obstetric Labor, Premature | 1 | 1996 | 85 | 0.130 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 1996 | 45 | 0.130 |
Why?
|
| Case-Control Studies | 2 | 2019 | 3231 | 0.120 |
Why?
|
| Amoxicillin | 1 | 1995 | 119 | 0.120 |
Why?
|
| Heart Transplantation | 2 | 2012 | 854 | 0.120 |
Why?
|
| Term Birth | 1 | 2014 | 32 | 0.120 |
Why?
|
| Thromboembolism | 1 | 1995 | 84 | 0.120 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 1994 | 29 | 0.120 |
Why?
|
| Recurrence | 2 | 2015 | 1412 | 0.120 |
Why?
|
| Herpes Genitalis | 1 | 1994 | 11 | 0.120 |
Why?
|
| Age Factors | 2 | 2019 | 2779 | 0.120 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1994 | 117 | 0.120 |
Why?
|
| Quality of Life | 1 | 2024 | 1905 | 0.120 |
Why?
|
| Risk Factors | 4 | 2021 | 9868 | 0.110 |
Why?
|
| Aneuploidy | 1 | 2014 | 156 | 0.110 |
Why?
|
| Glucocorticoids | 1 | 1996 | 379 | 0.110 |
Why?
|
| Fibrinolytic Agents | 1 | 1995 | 199 | 0.110 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1995 | 223 | 0.110 |
Why?
|
| Catheterization, Central Venous | 1 | 1994 | 131 | 0.110 |
Why?
|
| Forecasting | 1 | 2014 | 349 | 0.110 |
Why?
|
| Heart-Assist Devices | 2 | 2012 | 1022 | 0.100 |
Why?
|
| Bacteriological Techniques | 1 | 2013 | 90 | 0.100 |
Why?
|
| Heart Atria | 1 | 1994 | 308 | 0.100 |
Why?
|
| Heart Failure, Systolic | 1 | 2012 | 32 | 0.100 |
Why?
|
| Dilatation | 2 | 2023 | 68 | 0.100 |
Why?
|
| Postpartum Period | 2 | 2023 | 205 | 0.090 |
Why?
|
| Mass Screening | 1 | 2015 | 779 | 0.090 |
Why?
|
| Myocarditis | 1 | 2011 | 119 | 0.080 |
Why?
|
| Surveys and Questionnaires | 1 | 2019 | 3611 | 0.080 |
Why?
|
| Thrombosis | 1 | 1994 | 517 | 0.080 |
Why?
|
| Costs and Cost Analysis | 1 | 2009 | 160 | 0.080 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2011 | 214 | 0.080 |
Why?
|
| Young Adult | 2 | 2020 | 8805 | 0.080 |
Why?
|
| Colony Count, Microbial | 1 | 2008 | 89 | 0.080 |
Why?
|
| Myocardial Infarction | 1 | 1996 | 996 | 0.080 |
Why?
|
| Cervical Length Measurement | 1 | 2007 | 3 | 0.070 |
Why?
|
| Diagnosis, Differential | 2 | 2007 | 1874 | 0.070 |
Why?
|
| Uterine Cervical Incompetence | 1 | 2007 | 6 | 0.070 |
Why?
|
| Decision Support Techniques | 1 | 2009 | 278 | 0.070 |
Why?
|
| Elective Surgical Procedures | 1 | 2007 | 161 | 0.060 |
Why?
|
| Aged | 2 | 2021 | 18779 | 0.060 |
Why?
|
| Adolescent | 3 | 2019 | 18971 | 0.060 |
Why?
|
| Texas | 2 | 2007 | 3508 | 0.060 |
Why?
|
| Male | 5 | 2019 | 59581 | 0.060 |
Why?
|
| Logistic Models | 2 | 2020 | 1767 | 0.050 |
Why?
|
| Patient Selection | 1 | 2007 | 681 | 0.050 |
Why?
|
| Patient Outcome Assessment | 1 | 2023 | 93 | 0.050 |
Why?
|
| Michigan | 1 | 2021 | 39 | 0.050 |
Why?
|
| Prevalence | 1 | 2008 | 2369 | 0.050 |
Why?
|
| Pelvic Pain | 1 | 2021 | 27 | 0.050 |
Why?
|
| Curettage | 1 | 2020 | 6 | 0.050 |
Why?
|
| Drug Implants | 1 | 2020 | 42 | 0.040 |
Why?
|
| Puerperal Disorders | 1 | 2020 | 46 | 0.040 |
Why?
|
| Social Determinants of Health | 1 | 2021 | 110 | 0.040 |
Why?
|
| Postnatal Care | 1 | 2020 | 51 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2021 | 329 | 0.040 |
Why?
|
| Birth Weight | 1 | 2021 | 334 | 0.040 |
Why?
|
| Incidence | 2 | 1997 | 3008 | 0.040 |
Why?
|
| Heart Defects, Congenital | 1 | 2011 | 1802 | 0.040 |
Why?
|
| Weight Gain | 1 | 2021 | 377 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2023 | 945 | 0.040 |
Why?
|
| Abdomen, Acute | 1 | 1997 | 13 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 397 | 0.030 |
Why?
|
| Trial of Labor | 1 | 1997 | 21 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 1997 | 275 | 0.030 |
Why?
|
| Arginine | 1 | 2018 | 303 | 0.030 |
Why?
|
| Contraindications | 1 | 1996 | 77 | 0.030 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2021 | 901 | 0.030 |
Why?
|
| Time Factors | 1 | 2006 | 6176 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2021 | 1412 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2020 | 1160 | 0.030 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1995 | 80 | 0.030 |
Why?
|
| Cesarean Section, Repeat | 1 | 1994 | 6 | 0.030 |
Why?
|
| Education, Medical, Continuing | 1 | 1995 | 140 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2023 | 4648 | 0.030 |
Why?
|
| History, 20th Century | 1 | 1995 | 383 | 0.030 |
Why?
|
| Obesity, Morbid | 1 | 1995 | 180 | 0.030 |
Why?
|
| Rectum | 1 | 2013 | 97 | 0.030 |
Why?
|
| Reoperation | 1 | 1995 | 807 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2021 | 3306 | 0.030 |
Why?
|
| Hemorrhage | 1 | 1995 | 457 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 1995 | 1081 | 0.020 |
Why?
|
| Body Surface Area | 1 | 2011 | 31 | 0.020 |
Why?
|
| Antibodies, Bacterial | 1 | 2013 | 382 | 0.020 |
Why?
|
| Infant, Premature | 1 | 1996 | 799 | 0.020 |
Why?
|
| Waiting Lists | 1 | 2012 | 220 | 0.020 |
Why?
|
| Obesity | 1 | 2021 | 1949 | 0.020 |
Why?
|
| North America | 1 | 2011 | 234 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 1005 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2012 | 665 | 0.020 |
Why?
|
| Shock, Cardiogenic | 1 | 2011 | 189 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2011 | 747 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 2012 | 0.020 |
Why?
|
| Survival Rate | 1 | 2012 | 2001 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 2793 | 0.020 |
Why?
|
| Cardiomyopathies | 1 | 2011 | 481 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2012 | 13837 | 0.020 |
Why?
|
| Premature Birth | 1 | 2007 | 380 | 0.010 |
Why?
|
| Child | 2 | 2012 | 24108 | 0.010 |
Why?
|
| Infant | 1 | 2011 | 12347 | 0.010 |
Why?
|